ERT Clinical
- Company typePrivate
- Founded1977
- HeadquartersPhiladelphia, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingSoftware
ERT Clinical firmographics
Firmographics- Name
- ERT Clinical
- Website
- https://ert.com
- Company type
- Private
- Founded year
- 1977
- Operating status
- Acquired
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
ERT Clinical industry classification
Industry- Product category
- Clinical Trial Endpoint Technology
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industries
- Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where ERT Clinical is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Markets served
ERT Clinical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Endpoint Technology Services: Provides clinical trial endpoint solutions including cardiac safety, eCOA, medical imaging, precision motion, and respiratory services to pharmaceutical companies, biotechs, and CROs across all trial phases.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
ERT Clinical product offering
Product offeringCore offering
ERT Clinical (now operating as Clario, part of Thermo Fisher Scientific) provides clinical trial endpoint technology and evidence generation services spanning cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion (wearable sensors), and respiratory solutions. The platform is unified by cloud-native Trial Enablement software and supports site-based, hybrid, and decentralized clinical trials across all phases (Phase I through IV) for pharmaceutical sponsors, biotechs, and contract research organizations in over 100 countries.
Product overview
ERT Clinical (now Clario, part of Thermo Fisher Scientific) offers a unified platform of clinical trial endpoint technologies. The portfolio includes five core solution areas: Cardiac Solutions (ECG, arrhythmia, blood pressure monitoring), eCOA (electronic clinical outcome assessments for CNS, oncology, and patient-reported outcomes), Medical Imaging (core lab services with AI-powered redaction), Precision Motion (wearable sensor-based digital endpoints), and Respiratory Solutions (spirometry, oscillometry, lung sounds). These are unified through Trial Enablement software for eligibility, analytics, and document management. The platform supports site-based, hybrid, and fully decentralized clinical trials across Phase I through Phase III/IV, with AI capabilities integrated across multiple solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiac Solutions Cardiac safety and efficacy endpoint solutions for all clinical trial phases. Includes arrhythmia analysis, blood pressure services, ECG monitoring from site-based to decentralized clinical trials (DCT) and Phase I-IV, Phase I/TQT cardiac assessment, and regulatory consultation with statistical analysis. Built for pharmaceutical sponsors, biotechs, and CROs seeking regulatory-ready cardiac safety evidence.
- eCOA (Electronic Clinical Outcome Assessment) Electronic clinical outcome assessment platform for capturing patient-, clinician-, and observer-reported outcomes across CNS, oncology, and other therapeutic areas. Includes eCOA Neuroscience, eCOA Swift for early-phase oncology, eCOA Rapid Start pre-validated assessments, eCOA Science Services, rater/participant/caregiver training, suicidal ideation monitoring with the exclusive self-reported eC-SSRS, and eCOA Rescue Studies for troubled trials.
- Medical Imaging Comprehensive medical imaging core lab services for clinical trials, including AI-powered image redaction, an imaging platform supporting multiple modalities (CT, MRI, endoscopy), and secure submission workflows compliant with 21 CFR Part 11 and EU GDPR. Designed for sponsors needing regulatory-grade imaging evidence across therapeutic areas.
- Precision Motion Wearable-sensor-based digital endpoint solution for measuring objective mobility outcomes in clinical trials, centered on the Opal V2R research-grade wearable sensor. Backed by more than 750 scientific publications and used for clinical and translational research applications across neurological, musculoskeletal, and other indications.
- Respiratory Solutions Pulmonary function testing solutions for clinical trials, including site-based spirometry, virtual home spirometry, cough and lung sound assessment, diffusing capacity (DLCO) testing, oscillometry for small airway function, spirometry with ePROs, and AI-enabled spirometry insights. Built for respiratory clinical trial sponsors and healthcare providers.
- Trial Enablement Cloud-native clinical trial software platform for participant screening, eligibility data management, business intelligence and analytics, endpoint and safety risk reporting, data exchange, and source document management. Provides the unified data and workflow layer underlying the company's cardiac, eCOA, medical imaging, precision motion, and respiratory solutions.
Quantifiable outcome
- 70% of FDA and EMA new drug approvals since 2015 involved Clario's technology
- +3 more outcomes
Companies that use ERT Clinical
Customer profileSegments5 records
Ideal customer profiles3 records
ERT Clinical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature8 records
ERT Clinical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Thermo Fisher ScientificflagshipThermo Fisher Scientific completed acquisition of Clario Holdings Inc., enabling pharma and biotech customers to accelerate innovation with deeper clinical insights. The acquisition was announced in October 2025 and completed in 2026, making Clario part of Thermo Fisher Scientific.
Scale indicators7 records
Expansion highlights5 records
ERT Clinical competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
ERT Clinical social profiles
Digital presenceERT Clinical compliance and trust
Trust signalCompliance3 records
ERT Clinical financial estimates
Financial estimateRevenue estimate
Valuation estimate
ERT Clinical leadership team
Management profileNumber of profiles
Profiles18 records
ERT Clinical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ERT Clinical M&A and investment
M&A and investmentM&A8 records
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ERT Clinical
What does ERT Clinical do?
ERT Clinical (now operating as Clario, part of Thermo Fisher Scientific) provides clinical trial endpoint technology and evidence generation services spanning cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion (wearable sensors), and respiratory solutions. The platform is unified by cloud-native Trial Enablement software and supports site-based, hybrid, and decentralized clinical trials across all phases (Phase I through IV) for pharmaceutical sponsors, biotechs, and contract research organizations in over 100 countries.
Is ERT Clinical a public or private company?
ERT Clinical is a private company. It is classified as corporate owned and is currently acquired.
When was ERT Clinical founded?
ERT Clinical was founded in 1977. It employs 1,001 to 5,000 people.
Where is ERT Clinical based?
ERT Clinical is headquartered in Philadelphia, United States, in the North America region.
How does ERT Clinical make money?
One revenue line is on record: clinical Trial Endpoint Technology Services.
Does ERT Clinical have an API?
No public API is recorded for ERT Clinical.
What industry is ERT Clinical in?
ERT Clinical's product category is Clinical Trial Endpoint Technology. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAOAN, Regulatory Submissions & Clinical Content Management (eCTD/Publishing). Its NAICS code is 5417 and its SIC code is 8731.